New Analysis Further Demonstrates Clinical Benefits and Return on Investment Associated with ProVation Order Sets, powered by UpToDate Decision Support

New Analysis Further Demonstrates Clinical Benefits and Return on Investment Associated with ProVation Order Sets

<0> Media Contact:Wolters Kluwer Health | ProVation MedicalVicki Moses, 813-727-9243Marketing Director </0>

ROI analyses were conducted on data from three hospitals including Southeast Alabama Medical Center (Dothan, AL) and FHN Memorial (Freeport, IL), all of which have implemented ProVation Order Sets with their CPOE systems. Summarized in a new report from IDC Health Insights, “”, Doc #HI242872, August 2013 (subscription required), the results demonstrate increased productivity for medical and clinical staff, gains in operating profit, improved physician satisfaction and expected financial incentives from federal initiatives such as Value-Based Purchasing and Meaningful Use.

A central component of a healthcare organization’s patient care and quality measures improvement strategy, ProVation Order Sets provides evidence-based order set templates for use in CPOE systems. Templates also include embedded links to UpToDate recommendations, thousands of UpToDate narratives and links to regulatory quality measure definitions, all of which can be delivered in the CPOE system for use at the point of care. Access to order sets within CPOE streamlines delivery of standardized care and helps drive improvements in patient safety, outcomes, clinician performance and regulatory compliance.

“As one of the most time-consuming steps in CPOE implementation, the efficient and thorough movement of clinical content stored in paper-based order sets to electronic systems is critical to success,” said Judy Hanover, Research Director, IDC Health Insights. “The business value of the ProVation content management system was repeatedly demonstrated through our review of these implementation projects. In the future health reform environment, order sets and other clinical content from EHR and CPOE systems will need to have portable, configurable designs that are easy to manage and review.”

The report will be the focus of a webinar, “Maximize ROI by Leveraging Evidence-based Order Sets and Clinical Content Management Systems," taking place October 9, 2013 at 11 a.m. CDT and featuring Hanover, IDC Vice President of Business Value Consulting Randy Perry, and a panel of ProVation customers. Registration for the webinar can be accessed .

“The value proposition of IT purchases in today’s healthcare climate has become a critical factor for future positioning and success,” Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health, Clinical Solutions. “Industry research repeatedly points to the ability of ProVation Order sets to deliver significant return on investment and high clinical value, and it is our intention to continue refining and advancing our products to help healthcare organizations reduce costs and improve outcomes.”

is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include , , , , , , , and .

Wolters Kluwer Health is part of , a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: .

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.